(Q84100191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

1 reference

Andrei Iagaru

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Erik S Mittra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Kristen Ganjoo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Susan J Knox

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Michael L Goris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

20 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

Molecular Imaging and Biology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

198-203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11307-009-0245-9

1 February 2020

exact match

0 references

cites work

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

1 reference

12 December 2020

Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop

1 reference

12 December 2020

Determinants of the antitumor effect of radiolabeled monoclonal antibodies.

1 reference

12 December 2020

Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry

1 reference

12 December 2020

Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation

1 reference

12 December 2020

Correlation of tumor sensitivity to low-dose-rate irradiation with G2/M-phase block and other radiobiological parameters

1 reference

12 December 2020

Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab

1 reference

12 December 2020

Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice

1 reference

12 December 2020

Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

1 reference

12 December 2020

131I-tositumomab therapy as initial treatment for follicular lymphoma.

1 reference

12 December 2020

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Clinical perspectives in lymphoma

1 reference

12 December 2020

Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas

1 reference

12 December 2020

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.

1 reference

12 December 2020

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.

1 reference

12 December 2020

The radioisotope contributes significantly to the activity of radioimmunotherapy.

1 reference

12 December 2020

10.1007/S11307-009-0245-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19543946%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference